BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meyers TA, Townsend D. Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy. Int J Mol Sci 2019;20:E4098. [PMID: 31443395 DOI: 10.3390/ijms20174098] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 14.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Zhang X, Wen Y, Li S, Lu X, Xu R, Li C. Endoplasmic Reticulum-Mitochondria Contacts: A Potential Therapy Target for Cardiovascular Remodeling-Associated Diseases. Front Cell Dev Biol 2021;9:774989. [PMID: 34858991 DOI: 10.3389/fcell.2021.774989] [Reference Citation Analysis]
2 Bennett JS, Kamp AN, Cripe LH, Hor KN. Electrocardiographic prediction of late gadolinium enhancement on cardiac magnetic resonance in Becker muscular dystrophy. Neuromuscular Disorders 2021. [DOI: 10.1016/j.nmd.2021.09.011] [Reference Citation Analysis]
3 Adorisio R, Mencarelli E, Cantarutti N, Calvieri C, Amato L, Cicenia M, Silvetti M, D'Amico A, Grandinetti M, Drago F, Amodeo A. Duchenne Dilated Cardiomyopathy: Cardiac Management from Prevention to Advanced Cardiovascular Therapies. J Clin Med 2020;9:E3186. [PMID: 33019553 DOI: 10.3390/jcm9103186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
4 Sullivan RT, Lam NT, Haberman M, Beatka MJ, Afzal MZ, Lawlor MW, Strande JL. Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model. BMC Cardiovasc Disord 2021;21:302. [PMID: 34130633 DOI: 10.1186/s12872-021-02112-4] [Reference Citation Analysis]
5 Gartz M, Haberman M, Prom MJ, Beatka MJ, Strande JL, Lawlor MW. A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in mdx Mice. J Cardiovasc Pharmacol Ther 2022;27:10742484221088655. [PMID: 35353647 DOI: 10.1177/10742484221088655] [Reference Citation Analysis]
6 Yao S, Chen Z, Yu Y, Zhang N, Jiang H, Zhang G, Zhang Z, Zhang B. Current Pharmacological Strategies for Duchenne Muscular Dystrophy. Front Cell Dev Biol 2021;9:689533. [PMID: 34490244 DOI: 10.3389/fcell.2021.689533] [Reference Citation Analysis]
7 Lionarons JM, de Groot IJM, Fock JM, Klinkenberg S, Vrijens DMJ, Vreugdenhil ACE, Medici-van den Herik EG, Cuppen I, Jaeger B, Niks EH, Hoogerhuis R, Platte-van Attekum N, Feron FJM, Faber CG, Hendriksen JGM, Vles JSH. Prevalence of Bladder and Bowel Dysfunction in Duchenne Muscular Dystrophy Using the Childhood Bladder and Bowel Dysfunction Questionnaire. Life (Basel) 2021;11:772. [PMID: 34440515 DOI: 10.3390/life11080772] [Reference Citation Analysis]
8 Dowling P, Gargan S, Zweyer M, Swandulla D, Ohlendieck K. Proteomic profiling of fatty acid binding proteins in muscular dystrophy. Expert Rev Proteomics 2020;17:137-48. [PMID: 32067530 DOI: 10.1080/14789450.2020.1732214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Fonseca AC, Almeida AG, Santos MO, Ferro JM. Neurological complications of cardiomyopathies. Handb Clin Neurol 2021;177:91-109. [PMID: 33632460 DOI: 10.1016/B978-0-12-819814-8.00001-9] [Reference Citation Analysis]
10 Parker LE, Landstrom AP. The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care. Prog Pediatr Cardiol 2021;62:101413. [PMID: 34776723 DOI: 10.1016/j.ppedcard.2021.101413] [Reference Citation Analysis]
11 Zschüntzsch J, Jouvenal PV, Zhang Y, Klinker F, Tiburcy M, Liebetanz D, Malzahn D, Brinkmeier H, Schmidt J. Long-term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy. J Cachexia Sarcopenia Muscle 2020;11:1018-31. [PMID: 32436338 DOI: 10.1002/jcsm.12569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Florian IA, Lupan I, Sur L, Samasca G, Timiș TL. To be, or not to be… Guillain-Barré Syndrome. Autoimmun Rev 2021;:102983. [PMID: 34718164 DOI: 10.1016/j.autrev.2021.102983] [Reference Citation Analysis]
13 Bevere M, Morabito C, Mariggiò MA, Guarnieri S. The Oxidative Balance Orchestrates the Main Keystones of the Functional Activity of Cardiomyocytes. Oxid Med Cell Longev 2022;2022:7714542. [PMID: 35047109 DOI: 10.1155/2022/7714542] [Reference Citation Analysis]
14 Wang H, Marrosu E, Brayson D, Wasala NB, Johnson EK, Scott CS, Yue Y, Hau KL, Trask AJ, Froehner SC, Adams ME, Zhang L, Duan D, Montanaro F. Proteomic analysis identifies key differences in the cardiac interactomes of dystrophin and micro-dystrophin. Hum Mol Genet 2021;30:1321-36. [PMID: 33949649 DOI: 10.1093/hmg/ddab133] [Reference Citation Analysis]
15 Power LC, Gusso S, Hornung TS, Jefferies C, Derraik JGB, Hofman PL, O'Grady GL. Exercise Cardiac Magnetic Resonance Imaging in Boys With Duchenne Muscular Dystrophy Without Cardiac Disease. Pediatr Neurol 2021;117:35-43. [PMID: 33662889 DOI: 10.1016/j.pediatrneurol.2020.12.011] [Reference Citation Analysis]
16 Peczkowski KK, Rastogi N, Lowe J, Floyd KT, Schultz EJ, Karaze T, Davis JP, Rafael-Fortney JA, Janssen PML. Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models. Front Physiol 2020;11:568909. [PMID: 33101056 DOI: 10.3389/fphys.2020.568909] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Echigoya Y, Trieu N, Duddy W, Moulton HM, Yin H, Partridge TA, Hoffman EP, Kornegay JN, Rohret FA, Rogers CS, Yokota T. A Dystrophin Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon Skipping. Int J Mol Sci 2021;22:13065. [PMID: 34884867 DOI: 10.3390/ijms222313065] [Reference Citation Analysis]
18 Esmaeili M, Vettukattil R. In Vivo Magnetic Resonance Spectroscopy Methods for Investigating Cardiac Metabolism. Metabolites 2022;12:189. [DOI: 10.3390/metabo12020189] [Reference Citation Analysis]
19 Vad OB, Paludan-Müller C, Ahlberg G, Kalstø SM, Ghouse J, Andreasen L, Haunsø S, Tveit A, Sajadieh A, Christophersen IE, Svendsen JH, Olesen MS. Loss-of-Function Variants in Cytoskeletal Genes Are Associated with Early-Onset Atrial Fibrillation. J Clin Med 2020;9:E372. [PMID: 32013268 DOI: 10.3390/jcm9020372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Brescia M, Chao YC, Koschinski A, Tomek J, Zaccolo M. Multi-Compartment, Early Disruption of cGMP and cAMP Signalling in Cardiac Myocytes from the mdx Model of Duchenne Muscular Dystrophy. Int J Mol Sci 2020;21:E7056. [PMID: 32992747 DOI: 10.3390/ijms21197056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Valera IC, Wacker AL, Hwang HS, Holmes C, Laitano O, Landstrom AP, Parvatiyar MS. Essential roles of the dystrophin-glycoprotein complex in different cardiac pathologies. Adv Med Sci 2021;66:52-71. [PMID: 33387942 DOI: 10.1016/j.advms.2020.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Rodriguez-Gonzalez M, Lubian-Gutierrez M, Cascales-Poyatos HM, Perez-Reviriego AA, Castellano-Martinez A. Role of the Renin-Angiotensin-Aldosterone System in Dystrophin-Deficient Cardiomyopathy. Int J Mol Sci 2020;22:E356. [PMID: 33396334 DOI: 10.3390/ijms22010356] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Squire J. Special Issue: The Actin-Myosin Interaction in Muscle: Background and Overview. Int J Mol Sci 2019;20:E5715. [PMID: 31739584 DOI: 10.3390/ijms20225715] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Mareedu S, Pachon R, Thilagavathi J, Fefelova N, Balakrishnan R, Niranjan N, Xie LH, Babu GJ. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice. Am J Physiol Heart Circ Physiol 2021;320:H200-10. [PMID: 33216625 DOI: 10.1152/ajpheart.00601.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ohlendieck K, Swandulla D. Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy. Pflugers Arch 2021;473:1813-39. [PMID: 34553265 DOI: 10.1007/s00424-021-02623-1] [Reference Citation Analysis]
26 Atmanli A, Chai AC, Cui M, Wang Z, Nishiyama T, Bassel-Duby R, Olson EN. Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy. Circ Res 2021;129:602-16. [PMID: 34372664 DOI: 10.1161/CIRCRESAHA.121.319579] [Reference Citation Analysis]
27 Tamiyakul H, Kemter E, Kösters M, Ebner S, Blutke A, Klymiuk N, Flenkenthaler F, Wolf E, Arnold GJ, Fröhlich T. Progressive Proteome Changes in the Myocardium of a Pig Model for Duchenne Muscular Dystrophy. iScience 2020;23:101516. [PMID: 32927262 DOI: 10.1016/j.isci.2020.101516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 He X, Liu J, Gu F, Chen J, Lu YW, Ding J, Guo H, Nie M, Kataoka M, Lin Z, Hu X, Chen H, Liao X, Dong Y, Min W, Deng ZL, Pu WT, Huang ZP, Wang DZ. Cardiac CIP protein regulates dystrophic cardiomyopathy. Mol Ther 2021:S1525-0016(21)00416-0. [PMID: 34400329 DOI: 10.1016/j.ymthe.2021.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Wong TWY, Ahmed A, Yang G, Maino E, Steiman S, Hyatt E, Chan P, Lindsay K, Wong N, Golebiowski D, Schneider J, Delgado-Olguín P, Ivakine EA, Cohn RD. A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic Dmd deletion exhibits progressive muscular dystrophy and early-onset cardiomyopathy. Dis Model Mech 2020;13:dmm045369. [PMID: 32988972 DOI: 10.1242/dmm.045369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zabłocka B, Górecki DC, Zabłocki K. Disrupted Calcium Homeostasis in Duchenne Muscular Dystrophy: A Common Mechanism behind Diverse Consequences. Int J Mol Sci 2021;22:11040. [PMID: 34681707 DOI: 10.3390/ijms222011040] [Reference Citation Analysis]
31 Gargan S, Dowling P, Zweyer M, Reimann J, Henry M, Meleady P, Swandulla D, Ohlendieck K. Mass Spectrometric Profiling of Extraocular Muscle and Proteomic Adaptations in the mdx-4cv Model of Duchenne Muscular Dystrophy. Life (Basel) 2021;11:595. [PMID: 34206383 DOI: 10.3390/life11070595] [Reference Citation Analysis]
32 Vang P, Baumann CW, Barok R, Larson AA, Dougherty BJ, Lowe DA. Impact of estrogen deficiency on diaphragm and leg muscle contractile function in female mdx mice. PLoS One 2021;16:e0249472. [PMID: 33788896 DOI: 10.1371/journal.pone.0249472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Florczyk-Soluch U, Polak K, Dulak J. The multifaceted view of heart problem in Duchenne muscular dystrophy. Cell Mol Life Sci 2021;78:5447-68. [PMID: 34091693 DOI: 10.1007/s00018-021-03862-2] [Reference Citation Analysis]
34 Howard ZM, Dorn LE, Lowe J, Gertzen MD, Ciccone P, Rastogi N, Odom GL, Accornero F, Chamberlain JS, Rafael-Fortney JA. Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model. JCI Insight 2021;6:146511. [PMID: 33651713 DOI: 10.1172/jci.insight.146511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Hermes TA, Mizobuti DS, da Rocha GL, da Silva HNM, Covatti C, Pereira ECL, Ferretti R, Minatel E. Tempol improves redox status in mdx dystrophic diaphragm muscle. Int J Exp Pathol 2020;101:289-97. [PMID: 33098599 DOI: 10.1111/iep.12376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
36 Roshmi RR, Yokota T. Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience. Clin Pharmacol 2021;13:235-42. [PMID: 34938127 DOI: 10.2147/CPAA.S288842] [Reference Citation Analysis]
37 Kipke J, Birnkrant DJ, Jin JB, Aneja A, Bahler RC. A systematic review of pharmacologic therapies for the cardiomyopathy of Duchenne muscular dystrophy. Pediatr Pulmonol 2021;56:782-95. [PMID: 33621446 DOI: 10.1002/ppul.25261] [Reference Citation Analysis]
38 Dowling P, Gargan S, Zweyer M, Henry M, Meleady P, Swandulla D, Ohlendieck K. Proteome-wide Changes in the mdx-4cv Spleen due to Pathophysiological Cross Talk with Dystrophin-Deficient Skeletal Muscle. iScience 2020;23:101500. [PMID: 32916630 DOI: 10.1016/j.isci.2020.101500] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
39 de Souza F, Bittar Braune C, Dos Santos Nucera APC. Duchenne muscular dystrophy: an overview to the cardiologist. Expert Rev Cardiovasc Ther 2020;18:867-72. [PMID: 32985912 DOI: 10.1080/14779072.2020.1828065] [Reference Citation Analysis]
40 Starosta A, Konieczny P. Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy. Cell Mol Life Sci 2021;78:4867-91. [PMID: 33825942 DOI: 10.1007/s00018-021-03821-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Bukovec KE, Hu X, Borkowski M, Jeffery D, Blemker SS, Grange RW. A novel ex vivo protocol to mimic human walking gait: implications for Duchenne muscular dystrophy. J Appl Physiol (1985) 2020;129:779-91. [PMID: 32881620 DOI: 10.1152/japplphysiol.00002.2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Du Y, Demillard LJ, Ren J. Sarcoplasmic Reticulum Ca2+ Dysregulation in the Pathophysiology of Inherited Arrhythmia: An Update. Biochemical Pharmacology 2022;200:115059. [DOI: 10.1016/j.bcp.2022.115059] [Reference Citation Analysis]
43 Morroni J, Schirone L, Valenti V, Zwergel C, Riera CS, Valente S, Vecchio D, Schiavon S, Ragno R, Mai A, Sciarretta S, Lozanoska-Ochser B, Bouchè M. Inhibition of PKCθ Improves Dystrophic Heart Phenotype and Function in a Novel Model of DMD Cardiomyopathy. Int J Mol Sci 2022;23:2256. [PMID: 35216371 DOI: 10.3390/ijms23042256] [Reference Citation Analysis]
44 Rattis BAC, Freitas AC, Oliveira JF, Calandrini-Lima JLA, Figueiredo MJ, Soave DF, Ramos SG, Celes MRN. Effect of Verapamil, an L-Type Calcium Channel Inhibitor, on Caveolin-3 Expression in Septic Mouse Hearts. Oxid Med Cell Longev 2021;2021:6667074. [PMID: 33927797 DOI: 10.1155/2021/6667074] [Reference Citation Analysis]
45 Sheikh O, Yokota T. Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies. Expert Opin Investig Drugs 2021;30:167-76. [PMID: 33393390 DOI: 10.1080/13543784.2021.1868434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
46 Morroni J, Schirone L, Vecchio D, Nicoletti C, D'Ambrosio L, Valenti V, Sciarretta S, Lozanoska-Ochser B, Bouchè M. Accelerating the Mdx Heart Histo-Pathology through Physical Exercise. Life (Basel) 2021;11:706. [PMID: 34357078 DOI: 10.3390/life11070706] [Reference Citation Analysis]
47 Jelinkova S, Vilotic A, Pribyl J, Aimond F, Salykin A, Acimovic I, Pesl M, Caluori G, Klimovic S, Urban T, Dobrovolna H, Soska V, Skladal P, Lacampagne A, Dvorak P, Meli AC, Rotrekl V. DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology. Front Bioeng Biotechnol 2020;8:535. [PMID: 32656189 DOI: 10.3389/fbioe.2020.00535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
48 Landmesser U, Poller W, Tsimikas S, Most P, Paneni F, Lüscher TF. From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases. Eur Heart J 2020;41:3884-99. [PMID: 32350510 DOI: 10.1093/eurheartj/ehaa229] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
49 Zeng B, Zhou M, Liu B, Shen F, Xiao R, Su J, Hu Z, Zhang Y, Gu A, Wu L, Liu X, Liang D. Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs. Biochem Biophys Res Commun 2021;545:40-5. [PMID: 33540285 DOI: 10.1016/j.bbrc.2021.01.056] [Reference Citation Analysis]